Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul E Harrington

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Current Medicinal Chemistry|January 29, 2008
Calcium sensing receptor activators: calcimimeticsPaul E Harrington, Christopher Fotsch
Journal of the American Chemical Society|April 22, 2004
Structure elucidation of (+)-amphidinolide a by total synthesis and NMR chemical shift analysisBarry M Trost, Paul E Harrington
Organic Letters|December 17, 2009
Facile synthesis of substituted 5-amino- and 3-amino-1,2,4-thiadiazoles from a common precursorPaul M Wehn, Paul E Harrington, John E Eksterowicz
Journal of the American Chemical Society|August 22, 2002
Asymmetric cyclopentannelation: camphor-derived auxiliaryPaul E Harrington, Tsuyoshi Murai, Chester Chu, et al.
Journal of the American Chemical Society|September 30, 2005
Total synthesis of (+)-amphidinolide A. Structure elucidation and completion of the synthesisBarry M Trost, Paul E Harrington, John D Chisholm, et al.
Journal of the American Chemical Society|September 30, 2005
Total synthesis of (+)-amphidinolide A. Assembly of the fragmentsBarry M Trost, Stephen T Wrobleski, John D Chisholm, et al.
Journal of Biochemical and Biophysical Methods|January 25, 2003
Enantiomeric resolution of a novel chiral cannabinoid receptor ligandGanesh A Thakur, Sonya L Palmer, Paul E Harrington, et al.
Journal of the American Chemical Society|March 18, 2005
Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecinBarry M Trost, Mathias U Frederiksen, Julien P N Papillon, et al.
Journal of Medicinal Chemistry|October 20, 2009
Discovery and optimization of substituted 1-(1-phenyl-1H-pyrazol-3-yl)methanamines as potent and efficacious type II calcimimeticsSteve F Poon, David J St Jean, Paul E Harrington, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell ViabilityPaul E Harrington, Kaustav Biswas, David Malwitz, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|January 29, 2008
Calcium sensing receptor activators: calcimimeticsPaul E Harrington, Christopher Fotsch
Journal of the American Chemical Society|April 22, 2004
Structure elucidation of (+)-amphidinolide a by total synthesis and NMR chemical shift analysisBarry M Trost, Paul E Harrington
Organic Letters|December 17, 2009
Facile synthesis of substituted 5-amino- and 3-amino-1,2,4-thiadiazoles from a common precursorPaul M Wehn, Paul E Harrington, John E Eksterowicz
Journal of the American Chemical Society|August 22, 2002
Asymmetric cyclopentannelation: camphor-derived auxiliaryPaul E Harrington, Tsuyoshi Murai, Chester Chu, et al.
Journal of the American Chemical Society|September 30, 2005
Total synthesis of (+)-amphidinolide A. Structure elucidation and completion of the synthesisBarry M Trost, Paul E Harrington, John D Chisholm, et al.
Journal of the American Chemical Society|September 30, 2005
Total synthesis of (+)-amphidinolide A. Assembly of the fragmentsBarry M Trost, Stephen T Wrobleski, John D Chisholm, et al.
Journal of Biochemical and Biophysical Methods|January 25, 2003
Enantiomeric resolution of a novel chiral cannabinoid receptor ligandGanesh A Thakur, Sonya L Palmer, Paul E Harrington, et al.
Journal of the American Chemical Society|March 18, 2005
Dinuclear asymmetric Zn aldol additions: formal asymmetric synthesis of fostriecinBarry M Trost, Mathias U Frederiksen, Julien P N Papillon, et al.
Journal of Medicinal Chemistry|October 20, 2009
Discovery and optimization of substituted 1-(1-phenyl-1H-pyrazol-3-yl)methanamines as potent and efficacious type II calcimimeticsSteve F Poon, David J St Jean, Paul E Harrington, et al.
ACS Medicinal Chemistry Letters|January 16, 2015
Unfolded Protein Response in Cancer: IRE1α Inhibition by Selective Kinase Ligands Does Not Impair Tumor Cell ViabilityPaul E Harrington, Kaustav Biswas, David Malwitz, et al.
Pageof 2